GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Calmark Sweden AB (FRA:9C7) » Definitions » EV-to-FCF

Calmark Sweden AB (FRA:9C7) EV-to-FCF : 0.65 (As of May. 08, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Calmark Sweden AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Calmark Sweden AB's Enterprise Value is €-1.33 Mil. Calmark Sweden AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was €-2.03 Mil. Therefore, Calmark Sweden AB's EV-to-FCF for today is 0.65.

The historical rank and industry rank for Calmark Sweden AB's EV-to-FCF or its related term are showing as below:

FRA:9C7' s EV-to-FCF Range Over the Past 10 Years
Min: -49.81   Med: -1.47   Max: 0.19
Current: 0.19

During the past 4 years, the highest EV-to-FCF of Calmark Sweden AB was 0.19. The lowest was -49.81. And the median was -1.47.

FRA:9C7's EV-to-FCF is ranked better than
94.23% of 104 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.955 vs FRA:9C7: 0.19

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-08), Calmark Sweden AB's stock price is €0.0002. Calmark Sweden AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was €-0.041. Therefore, Calmark Sweden AB's PE Ratio for today is At Loss.


Calmark Sweden AB EV-to-FCF Historical Data

The historical data trend for Calmark Sweden AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calmark Sweden AB EV-to-FCF Chart

Calmark Sweden AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EV-to-FCF
- - -5.86 -1.05

Calmark Sweden AB Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.00 -1.05 -0.90 -0.85 -0.54

Competitive Comparison of Calmark Sweden AB's EV-to-FCF

For the Diagnostics & Research subindustry, Calmark Sweden AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Calmark Sweden AB's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Calmark Sweden AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Calmark Sweden AB's EV-to-FCF falls into.



Calmark Sweden AB EV-to-FCF Calculation

Calmark Sweden AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=-1.327/-2.029
=0.65

Calmark Sweden AB's current Enterprise Value is €-1.33 Mil.
Calmark Sweden AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Calmark Sweden AB  (FRA:9C7) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Calmark Sweden AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0002/-0.041
=At Loss

Calmark Sweden AB's share price for today is €0.0002.
Calmark Sweden AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.041.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Calmark Sweden AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Calmark Sweden AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Calmark Sweden AB (FRA:9C7) Business Description

Traded in Other Exchanges
Address
Sommargatan 101A, Karlstad Innovation Park, lokal Manegen, Karlstad, SWE, SE-656 37
Calmark Sweden AB provides tests for a newborn. The company's product Calmark's developed a point-of-care (POC) diagnostic instrument which makes it easier and faster to measure biomarkers for disease states in newborns. The company's PNA instrument consists of a reader and a disposable product that is placed in the reader when measured.

Calmark Sweden AB (FRA:9C7) Headlines

No Headlines